News | October 12, 2022
Marksans to acquire Tevapharm's bulk formulations business
Plans to double its manufacturing footprint to bolster the growth
Plans to double its manufacturing footprint to bolster the growth
This new facility integrates multi-channel chip, micro-mixer system, and complex preparation system into a multi-channel micro-mixer core LNP manufacturing platform
The combined company will be able to better serve both our global and regional customers with local production
The company has been issued a Form 483 with two observations which the company will address within the stipulated timeline.
The ground floor of the formulation development laboratory is focused on solid orals, the first floor on injections, and the second floor houses the analytical lab
Anand Rathi maintains long-term guidance of 10-15% revenue growth and 40% EBITDA margins
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
Despite advances over the past 20 years, ovarian cancer treatment requires better standard of care
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
Domestic business was up 41.9% YoY and 27.7% QoQ
Subscribe To Our Newsletter & Stay Updated
